Autism at 1 in 91 Children: SafeMinds calls for Thimerosal Ban from Seasonal & H1N1 Flu Vaccine
Posted Oct 05 2009 12:00am
Autism Prevalence Now At 1 in 91 Children, 1 in 58 Boys SafeMinds Calls For A Ban on Thimerosal from Seasonal and H1N1 Flu Vaccines In Pregnant Women and Young Children
Monday, October 5, 2009, Reston, VA - Today the Maternal & Child Health Bureau of Health Resources and Services Administration (HRSA), US Department of Health and Human Services released a study evaluating the number of children in the U.S. who currently have a Autism Spectrum Disorder (ASD) diagnosis, The Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder among Children in the United States, 2007. The Study evaluated data from a national Survey of Children’s Health and found that 1 in 91 children between the ages of 3 and 17 currently carry an ASD diagnosis -1 in 58 boys.
Even more alarming, for the subset of children between ages 6 and 14 immunized during the 1990’s the prevalence is actually 1 in 71 children with an autism diagnosis. This age group represents children in the U.S. with the highest exposure to thimerosal, the mercury preservative routinely used until CDC, AAP and industry recommended its removal "as soon as possible" from all childhood vaccines. Despite this recommendation, mercury, one of the most neurotoxic substances on the planet, is still used in most seasonal and H1N1 vaccines.